Keyphrases
Cardiovascular Disease
73%
People Living with HIV (PLHIV)
66%
Antiretroviral Therapy
47%
Cardiovascular Risk
41%
Hepatitis C Virus Infection
36%
Hepatitis C Virus
35%
Peri
34%
Coronary Inflammation
31%
HIV Patients
31%
Atherosclerotic Cardiovascular Disease (ASCVD)
30%
HIV Infection
29%
Coronary Artery
28%
Endothelial Function
27%
Fat Attenuation Index
26%
Coronary Endothelial Function
23%
Inflammation Markers
22%
T Cells
21%
HCV Infection
20%
Systematic Meta-analysis
19%
Chronic HCV Infection
19%
Global Burden
19%
Chronic Hepatitis C Virus Infection
19%
Direct-acting Antiviral Therapy
19%
Sustained Virological Response
15%
AIDS/HIV
15%
Right Coronary Artery
13%
Atherosclerotic Vascular Disease
12%
Inflammation
12%
Left Anterior Descending Artery
11%
Zambia
11%
Systemic Markers
11%
Human Immunodeficiency Virus Infection
11%
Programmed Death-ligand 1 (PD-L1)
11%
Disability-adjusted Life Years
10%
Vascular Health
10%
Cardiovascular Risk Markers
10%
Meta-analysis
10%
Coronary Endothelial Dysfunction
10%
Infected Population
9%
Combined Antiretroviral Therapy (cART)
9%
HIV-associated Cardiomyopathy
9%
Refeeding Syndrome
9%
Therapy Success
9%
Lipoproteins
9%
Grazoprevir
9%
Elbasvir
9%
Zepatier
9%
High Cardiovascular Risk
9%
Soluble Markers
9%
Acute Coronary Syndrome
9%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Cardiovascular Disease
58%
Human Immunodeficiency Virus Infection
37%
Hepatitis C Virus
33%
Antiretroviral Therapy
26%
Hepatitis C
25%
Infection
23%
Systematic Review
20%
Coronary Artery
19%
Meta-Analysis
19%
T Cell
19%
Mixed Infection
14%
Biological Marker
13%
Immunity
12%
Cardiovascular Risk
12%
Vascular Disease
11%
Magnetic Resonance Imaging
11%
Right Coronary Artery
11%
Endothelial Function
11%
Pulmonary Hypertension
9%
Chronic Hepatitis C
9%
Antiviral Therapy
9%
Cytotoxic T-Cell
9%
Refeeding Syndrome
9%
Lipoprotein
9%
Endothelial Dysfunction
9%
Multimodality Imaging
9%
Body Fat Distribution
9%
Cardiometabolic Risk
9%
Hypophosphatemia
9%
Hypokalemia
9%
Receptor
9%
Myocardial Disease
9%
Acute Coronary Syndrome
9%
Case-Control Study
9%
Disability Adjusted Life Years
8%
Atherosclerosis
7%
CD8 Antigen
6%
Immunocompetent Cell
5%
Diseases
5%
Cross Sectional Study
5%
Immunology and Microbiology
Human Immunodeficiency Virus
82%
T Cell
29%
Human Immunodeficiency Virus Infection
23%
Hepatitis C Virus
19%
Coinfection
14%
Immunity
14%
Magnetic Resonance Imaging
12%
Hepatitis C
11%
Coronary Artery
11%
Lipoprotein
9%
Human Immunodeficiency Virus 1
9%
CD4 Lymphocyte Count
9%
Cytotoxic T-Cell
9%
Gamma Delta T Cell
9%
Right Coronary Artery
7%
CD8
6%
Artery
5%
Immunocompetent Cell
5%
CD38
5%
Viral Clearance
5%
